ENLIVEX THERAPEUTICS LTD (ENLV) Stock Cash Flow
NASDAQ:ENLV - Nasdaq - IL0011319527 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -18.93M | -29.07M | -31.06M | -14.47M | -11.82M | |||
| Depreciation Amortization | 709.00K | 835.00K | 780.00K | 550.00K | 290.00K | |||
| Change In Working Capital | 3.37M | 2.43M | 800.00K | -1.36M | -310.00K | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 649.00K | 2.28M | 5.53M | -2.26M | 840.00K | |||
| OPERATING CASH FLOW | -14.20M | -23.52M | -23.95M | -17.54M | -11.01M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -75.00K | -236.00K | -8.12M | -1.63M | -1.02M | |||
| Other Investing Activity | 9.91M | -25.73M | 70.65M | -36.78M | -19.96M | |||
| INVESTING CASH FLOW | 9.84M | -25.97M | 62.52M | -38.41M | -20.98M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 5.19M | 360.00K | 150.00K | 60.98M | 33.08M | |||
| FINANCING CASH FLOW | 5.19M | 360.00K | 150.00K | 60.98M | 33.08M | |||
| Exchange Rate Effect | N/A | 0.00 | 0.00 | -410.00K | 390.00K | |||
| CHANGE IN CASH | 828.00K | -49.13M | 38.72M | 4.62M | 1.48M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -14.20M | -23.52M | -23.95M | -17.54M | -11.01M | |||
| Capital Expenditure | -75.00K | -236.00K | -8.12M | -1.63M | -1.02M | |||
| FREE CASH FLOW | -14.28M | -23.76M | -32.07M | -19.17M | -12.03M | |||
All data in USD